Merit Medical Systems Inc (MMSI)

$85.52

+0.52

(+0.61%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $84.68
    $85.94
    $85.52
    downward going graph

    0.98%

    Downside

    Day's Volatility :1.47%

    Upside

    0.49%

    downward going graph
  • $62.58
    $88.85
    $85.52
    downward going graph

    26.82%

    Downside

    52 Weeks Volatility :29.57%

    Upside

    3.75%

    downward going graph

Returns

PeriodMerit Medical Systems IncSector (Health Care)Index (Russel 2000)
3 Months
15.21%
6.5%
0.0%
6 Months
8.81%
7.1%
0.0%
1 Year
17.24%
9.8%
0.0%
3 Years
32.9%
14.2%
-20.2%

Highlights

Market Capitalization
5.1B
Book Value
$21.35
Earnings Per Share (EPS)
1.74
PE Ratio
50.0
PEG Ratio
1.91
Wall Street Target Price
96.36
Profit Margin
7.94%
Operating Margin TTM
11.07%
Return On Assets TTM
4.25%
Return On Equity TTM
8.45%
Revenue TTM
1.3B
Revenue Per Share TTM
22.22
Quarterly Revenue Growth YOY
8.7%
Gross Profit TTM
519.1M
EBITDA
229.4M
Diluted Eps TTM
1.74
Quarterly Earnings Growth YOY
0.33
EPS Estimate Current Year
3.29
EPS Estimate Next Year
3.67
EPS Estimate Current Quarter
0.71
EPS Estimate Next Quarter
0.88

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Merit Medical Systems Inc(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
12
Hold
3
3
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 12.68%

Current $85.52
Target $96.36

Company Financials

FY18Y/Y Change
Revenue
882.8M
↑ 21.28%
Net Income
42.0M
↑ 52.66%
Net Profit Margin
4.76%
↑ 0.98%
FY19Y/Y Change
Revenue
994.9M
↑ 12.7%
Net Income
5.5M
↓ 87.03%
Net Profit Margin
0.55%
↓ 4.21%
FY20Y/Y Change
Revenue
963.9M
↓ 3.11%
Net Income
-9.8M
↓ 280.57%
Net Profit Margin
-1.02%
↓ 1.57%
FY21Y/Y Change
Revenue
1.1B
↑ 11.5%
Net Income
48.5M
↓ 592.27%
Net Profit Margin
4.51%
↑ 5.53%
FY22Y/Y Change
Revenue
1.2B
↑ 7.09%
Net Income
74.5M
↑ 53.79%
Net Profit Margin
6.47%
↑ 1.96%
FY23Y/Y Change
Revenue
1.3B
↑ 8.89%
Net Income
94.4M
↑ 26.7%
Net Profit Margin
7.53%
↑ 1.06%
Q4 FY22Q/Q Change
Revenue
293.4M
↑ 2.17%
Net Income
33.4M
↑ 118.71%
Net Profit Margin
11.38%
↑ 6.06%
Q1 FY23Q/Q Change
Revenue
297.6M
↑ 1.41%
Net Income
20.7M
↓ 38.02%
Net Profit Margin
6.96%
↓ 4.42%
Q2 FY23Q/Q Change
Revenue
320.1M
↑ 7.56%
Net Income
20.2M
↓ 2.21%
Net Profit Margin
6.33%
↓ 0.63%
Q3 FY23Q/Q Change
Revenue
315.2M
↓ 1.51%
Net Income
25.8M
↑ 27.61%
Net Profit Margin
8.2%
↑ 1.87%
Q4 FY23Q/Q Change
Revenue
323.3M
↑ 2.56%
Net Income
27.6M
↑ 6.95%
Net Profit Margin
8.55%
↑ 0.35%
Q1 FY24Q/Q Change
Revenue
323.5M
↑ 0.07%
Net Income
28.2M
↑ 2.21%
Net Profit Margin
8.73%
↑ 0.18%
FY18Y/Y Change
Total Assets
1.6B
↑ 45.71%
Total Liabilities
687.2M
↑ 57.81%
FY19Y/Y Change
Total Assets
1.8B
↑ 8.48%
Total Liabilities
807.4M
↑ 17.48%
FY20Y/Y Change
Total Assets
1.7B
↓ 5.29%
Total Liabilities
705.8M
↓ 12.58%
FY21Y/Y Change
Total Assets
1.6B
↓ 0.97%
Total Liabilities
608.5M
↓ 13.79%
FY22Y/Y Change
Total Assets
1.7B
↑ 0.95%
Total Liabilities
519.6M
↓ 14.61%
FY23Y/Y Change
Total Assets
2.3B
↑ 39.74%
Total Liabilities
1.1B
↑ 116.19%
Q4 FY22Q/Q Change
Total Assets
1.7B
↑ 1.91%
Total Liabilities
519.6M
↓ 4.47%
Q1 FY23Q/Q Change
Total Assets
1.7B
↑ 1.21%
Total Liabilities
512.5M
↓ 1.37%
Q2 FY23Q/Q Change
Total Assets
1.8B
↑ 9.11%
Total Liabilities
633.9M
↑ 23.69%
Q3 FY23Q/Q Change
Total Assets
1.8B
↓ 1.58%
Total Liabilities
578.6M
↓ 8.72%
Q4 FY23Q/Q Change
Total Assets
2.3B
↑ 28.57%
Total Liabilities
1.1B
↑ 94.12%
Q1 FY24Q/Q Change
Total Assets
2.3B
↑ 0.05%
Total Liabilities
1.1B
↓ 3.3%
FY18Y/Y Change
Operating Cash Flow
86.5M
↑ 37.95%
Investing Cash Flow
-378.8M
↑ 158.12%
Financing Cash Flow
328.3M
↑ 240.13%
FY19Y/Y Change
Operating Cash Flow
77.8M
↓ 10.08%
Investing Cash Flow
-134.5M
↓ 64.5%
Financing Cash Flow
33.5M
↓ 89.79%
FY20Y/Y Change
Operating Cash Flow
165.3M
↑ 112.39%
Investing Cash Flow
-58.7M
↓ 56.39%
Financing Cash Flow
-95.7M
↓ 385.41%
FY21Y/Y Change
Operating Cash Flow
147.2M
↓ 10.91%
Investing Cash Flow
-37.2M
↓ 36.64%
Financing Cash Flow
-98.4M
↑ 2.85%
FY22Y/Y Change
Operating Cash Flow
114.3M
↓ 22.37%
Investing Cash Flow
-57.4M
↑ 54.45%
Financing Cash Flow
-60.3M
↓ 38.78%
Q4 FY22Q/Q Change
Operating Cash Flow
28.0M
↓ 21.08%
Investing Cash Flow
-17.3M
↑ 3.34%
Financing Cash Flow
-5.7M
↓ 78.76%
Q1 FY23Q/Q Change
Operating Cash Flow
14.5M
↓ 48.07%
Investing Cash Flow
-14.9M
↓ 14.27%
Financing Cash Flow
-497.0K
↓ 91.36%
Q2 FY23Q/Q Change
Operating Cash Flow
17.3M
↑ 18.84%
Investing Cash Flow
-142.9M
↑ 861.87%
Financing Cash Flow
141.5M
↓ 28572.03%

Technicals Summary

Sell

Neutral

Buy

Merit Medical Systems Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Merit Medical Systems Inc
Merit Medical Systems Inc
2.46%
8.81%
17.24%
32.9%
107.32%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Merit Medical Systems Inc
Merit Medical Systems Inc
50.0
50.0
1.91
3.29
0.08
0.04
NA
21.35
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Merit Medical Systems Inc
Merit Medical Systems Inc
Buy
$5.1B
107.32%
50.0
7.94%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%

Insights on Merit Medical Systems Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 315.23M → 323.50M (in $), with an average increase of 1.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 20.24M → 28.24M (in $), with an average increase of 10.1% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 15.4%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 2.7%

Institutional Holdings

  • BlackRock Inc

    16.36%

  • Vanguard Group Inc

    11.74%

  • William Blair Investment Management, LLC

    5.24%

  • State Street Corporation

    3.86%

  • ArrowMark Colorado Holdings, LLC (ArrowMark Partners)

    3.76%

  • Conestoga Capital Advisors, LLC

    3.74%

Company Information

merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c

Organization
Merit Medical Systems Inc
Employees
6950
CEO
Mr. Fred P. Lampropoulos
Industry
Health Technology

Discover More

FAQs